Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
To test the feasibility of theranostic targeting the PSMA receptor in STS patients by
Ga-68-PSMA-11 PET/CT and Lu-177-ITG-PSMA-1 treat-ment with special emphasis on vascular
disruption using a translational approach.